Focus: Fate Therapeutics is a public biotechnology company focused on stem cell-modulating therapeutics and cell therapy, headquartered in San Diego with a pipeline of 24 clinical programs spanning oncology, hematologic malignancies, and autoimmune indications.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
High technical upside in cell therapy for specialists willing to accept significant financial risk and career uncertainty in a pre-revenue, cash-constrained biotech.
Help build intelligence for Fate Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Fate Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Fate Therapeutics Inc (FATE) Valuation: PE, PB & Fair Value Analysis - tradingkey.com
Fate Therapeutics Inc (FATE) Valuation: PE, PB & Fair Value Analysis tradingkey.com
Irenic Capital Management LP Purchases Shares of 878,055 Fate Therapeutics, Inc. $FATE - MarketBeat
Irenic Capital Management LP Purchases Shares of 878,055 Fate Therapeutics, Inc. $FATE MarketBeat
Fate Therapeutics Inc (FATE) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
Fate Therapeutics Inc (FATE) Risk Assessment: Volatility, Financial Risk & Investment Risk tradingkey.com
Fate Therapeutics Inc (FATE) Institutional Confidence - tradingkey.com
Fate Therapeutics Inc (FATE) Institutional Confidence tradingkey.com
FATE|Fate Therapeutics Inc|Price:2.325|Chg%:-0.105 - tradingkey.com
FATE|Fate Therapeutics Inc|Price:2.325|Chg%:-0.105 tradingkey.com
Fate Therapeutics Inc (FATE) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Fate Therapeutics Inc (FATE) Financial Health: Profitability & Balance Sheet Analysis tradingkey.com
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo